RATIONALE-306 subgroup analysis of patients (pts) with advanced/metastatic esophageal squamous cell cancer (ESCC) and tumor area positivity (TAP) score ≳5%

Item

RATIONALE-306 subgroup analysis of patients (pts) with advanced/metastatic esophageal squamous cell cancer (ESCC) and tumor area positivity (TAP) score ≳5%

Tougeron, D.
;
Xu, J.
;
Raymond, E.
;
Hubner, R.
;
Kato, K.
;
Wyrwicz, L. S.
;
Van Cutsem, E.
;
Park, S. R.
;
Fonseca, P. J.
;
Kojima, T.
... show 9 more

Citations

Google Scholar:

Altmetric:

Authors

Tougeron, D.
Xu, J.
Raymond, E.
Hubner, R.
Kato, K.
Wyrwicz, L. S.
Van Cutsem, E.
Park, S. R.
Fonseca, P. J.
Kojima, T.
Ishihara, R.
Avallone, A.
Cid, R. A. P.
Wang, K.
Yan, S.
Shi, J.
Kong, X.
Yoon, H.
Lordick, F.

Affiliation

Jean Bernard Hop, Gastroentrol, CHU Poitiers, Poitiers, France Chinese PLA Hosp, Fifth Med Ctr Chinese PLA Gen Hosp, Gastrointestinal Dept, 307 South Campus, Beijing, Peoples R China Hop St Joseph, Med Oncol, Grp Hosp Paris St Joseph, Paris, France Christie NHS Fdn Trust, Med Oncol, Manchester, England Natl Canc Ctr, Dept Gastrointestinal Med Oncol, Tsukiji Campus,Chuo Ku, Tokyo, Japan Maria Sklodowska Curie Natl Res Inst Oncol, Dept Oncol & Radiotherapy, Warsaw, Poland UZ Leuven, Digest Oncol Dept, Univ Hosp Leuven, Campus Gasthuisberg, Leuven, Belgium Univ Ulsan, Dept Oncol, Asan Med Ctr, Seoul, South Korea Hosp Univ Cent Asturias, Med Oncol, Oviedo, Spain Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Japan OICI Osaka Int Canc Inst, Gastrointestinal Oncol, Osaka, Japan Ist Nazl Tumori IRCCS Fdn G Pascale, Med Oncol, Naples, Italy Hosp Univ Miguel Servet, Med Oncol, Zaragoza, Spain BeOne Med Co Inc, Global Stat & Data Sci, San Mateo, CA USA BeOne Med Beijing Co Ltd, Clin Dev, Beijing, Peoples R China BeOne Med Beijing Co Ltd, Clin Biomarker, Beijing, Peoples R China BeOne Med Shanghai Co Ltd, Clin Dev, Shanghai, Peoples R China Mayo Clin, Oncol, Rochester, MN USA Univ Krebsze Krebszentrum Leipzig, Univ Klinikum Leipzig, Dept Med, Leipzig, Germany

Date

2025

Collections

All Christie Publications

Show all metadata

Type

Meetings and Proceedings

Citation

Tougeron D, Xu J, Raymond E, Hubner R, Kato K, Wyrwicz LS, et al. RATIONALE-306 subgroup analysis of patients (pts) with advanced/metastatic esophageal squamous cell cancer (ESCC) and tumor area positivity (TAP) score ≳5%. ANNALS OF ONCOLOGY. 2025 JUL;36. PubMed PMID: WOS:001545624000066. English.

URI

https://christie.openrepository.com/handle/10541/628045